Adjuvant Chemotherapy of Breast Cancer pp 102-109 | Cite as
Ludwig Breast Cancer Trial LBCS III: Chemo- and Endocrine Adjuvant Treatment in Postmenopausal Patients
Chapter
Abstract
In 1978 the Ludwig Breast Cancer Study (LBCS) Group initiated four complementary randomized controlled clinical trials to evaluate adjuvant therapy in both pre- and postmenopausal patients with operable breast cancer and axillary lymph node involvement. The trial in postmenopausal patients 65 years old or younger (LBCS III), in which the combination of endocrine therapy with multiple cytotoxic chemotherapy was compared with endocrine therapy alone and with no adjuvant treatment after mastectomy, is the subject of this report (Fig. 1).
Keywords
Breast Cancer Estrogen Receptor Endocrine Therapy Basal Cell Carcinoma Estrogen Receptor Status
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Preview
Unable to display preview. Download preview PDF.
References
- 1.Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observation. J Am Statist Assoc 53: 457–481CrossRefGoogle Scholar
- 2.Peto R, Pike MC, Armitage P, Breslow NE et al. (1977) Design and analysis of randomized clinical trials requiring prolonged observation of each patient. Br J Cancer 35: 1–39PubMedCrossRefGoogle Scholar
- 3.Cox DR (1972) Regression models and life tables (with discussion). J Roy Statist Soc B (Methodol) 34: 187–220Google Scholar
- 4.Bonadonna G, Rossi A, Valagussa P, Banfi A, Veronesi U (1977) The CMF programm for operable breast cancer with positive axillary nodes. Cancer 39: 2904–2915PubMedCrossRefGoogle Scholar
Copyright information
© Springer-Verlag Berlin · Heidelberg 1984